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Negative Autoregulation by Fas Stabilizes Adult
Erythropoiesis and Accelerates Its Stress Response
Miroslav Koulnis, Ying Liu, Kelly Hallstrom, Merav Socolovsky*
Department of Pediatrics and Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
Abstract
Erythropoiesis maintains a stable hematocrit and tissue oxygenation in the basal state, while mounting a stress response
that accelerates red cell production in anemia, blood loss or high altitude. Thus, tissue hypoxia increases secretion of the
hormone erythropoietin (Epo), stimulating an increase in erythroid progenitors and erythropoietic rate. Several cell divisions
must elapse, however, before Epo-responsive progenitors mature into red cells. This inherent delay is expected to reduce
the stability of erythropoiesis and to slow its response to stress. Here we identify a mechanism that helps to offset these
effects. We recently showed that splenic early erythroblasts, ‘EryA’, negatively regulate their own survival by co-expressing
the death receptor Fas, and its ligand, FasL. Here we studied mice mutant for either Fas or FasL, bred onto an immune-
deficient background, in order to avoid an autoimmune syndrome associated with Fas deficiency. Mutant mice had a higher
hematocrit, lower serum Epo, and an increased number of splenic erythroid progenitors, suggesting that Fas negatively
regulates erythropoiesis at the level of the whole animal. In addition, Fas-mediated autoregulation stabilizes the size of the
splenic early erythroblast pool, since mutant mice had a significantly more variable EryA pool than matched control mice.
Unexpectedly, in spite of the loss of a negative regulator, the expansion of EryA and ProE progenitors in response to high
Epo in vivo, as well as the increase in erythropoietic rate in mice injected with Epo or placed in a hypoxic environment,
lagged significantly in the mutant mice. This suggests that Fas-mediated autoregulation accelerates the erythropoietic
response to stress. Therefore, Fas-mediated negative autoregulation within splenic erythropoietic tissue optimizes key
dynamic features in the operation of the erythropoietic network as a whole, helping to maintain erythroid homeostasis in
the basal state, while accelerating the stress response.
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Introduction
The production of red blood cells (Erythropoiesis) is continuous
throughout life, maintaining an optimal number of circulating red
cells and tissue oxygen tension (pO2). A decrease in tissue pO2, as
may occur in anemia, bleeding, high altitude or respiratory disease,
drives erythropoiesis up to 10 fold its basal rate. This response is
regulated through a negative feedback loop in which decreasing
tissue pO2 increases synthesis of the hormone Epo ([1,2,3], Fig 1A).
Epo-mediated activation of its receptor, EpoR [4], on erythroid
progenitors increases their number and consequently, erythropoi-
etic rate and tissue pO2. During accelerated rates of erythropoiesis,
Epo cooperates with additional factors, notably glucocorticoid
hormones and stem cell factor [5,6,7,8].
Epo controls an early cellular compartment within the
‘erythroblastic island’, the developmental niche on the surface of
a macrophage that supports erythroid maturation [9] (Fig 1A).
Three to five cell divisions must elapse before cells in this early
compartment mature into red blood cells. This inherent delay in
the pO2/Epo-regulated feedback loop is likely to compromise the
stability and rapid stress response of the erythropoietic system.
Additional control mechanisms may therefore exist to compensate
for this inherent delay.
The earliest Epo-dependent progenitor is the ‘Colony-forming
Unit-erythroid’ or CFU-e, giving rise to colonies of at least 8 red
cells within 48–72 hours in vitro [10]. Its erythroblast progeny are
classified by their morphology [11]. We previously developed a
flow-cytometric approach to identify erythroblasts directly in
freshly-harvested mouse hematopoietic tissue, using cell surface
markers CD71, Ter119 and cell size, measured by flow-cytometric
forward scatter (FSC). We classify increasingly mature erythroid
precursors subsets as ‘ProE’ (CD71highTer119med), ‘EryA’
(CD71highTer119highFSChigh), ‘EryB’ (CD71highTer119highFSClow)
and ‘EryC’ (CD71lowTer119highFSClow)[12] (Fig 1A–B). We found
that, in addition to the well documented increase in CFU-e
[13,14], the early erythroblast subsets ProE and EryA are
responsive to EpoR signaling in vivo [12].
Epo promotes erythroblast survival in vitro [15], suggesting this
mechanism may underlie its regulation of erythropoietic rate. Our
recent experiments in vivo [12] confirm this hypothesis. During
basal erythropoiesis, the majority of ProE and EryA undergo
apoptosis, particularly in spleen, the murine organ of erythropoi-
etic reserve [16]. During stress, high Epo decreases their apoptosis,
increasing ProE and EryA number [12]. The reasons for this
apparently wasteful mechanism of erythropoietic rate regulation
have not been addressed experimentally.
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EpoR activates several survival pathways, including Stat5-
mediated induction of bcl-xL [17,18,19,20], other Stat5 targets
[21,22,23,24] and the EpoR-activated phosphoinositide 3-kinase
(PI3K) -AKT pathway [25,26]. The death receptor Fas, and its
ligand, FasL, were first proposed to contribute to erythroid
homeostasis based on their expression in human bone-marrow
[27]. We found that, in vivo in the mouse, splenic ProE and EryA,
but not their bone-marrow counterparts, co-express Fas and FasL.
During stress, high Epo suppresses their Fas expression, strongly
correlating with their decreased apoptosis [12]. These findings
suggested the hypothesis that, in the basal state, splenic ProE and
EryA negatively regulate their own survival through Fas and FasL-
mediated inter-cellular interactions; and that Epo-mediated Fas
suppression is a key mechanism regulating erythropoietic expan-
sion during stress (Fig 1A) [12].
Negative autoregulation through co-expression of Fas and FasL
was previously implicated in terminating the clonal expansion of
activated T cells [28,29,30]. Similarly, we recently found that Fas
and FasL co-expression in fetal liver erythroid progenitors
terminates their initial wave of expansion at the onset of fetal
erythropoiesis [31]. Here we set out to assess the contribution of
Fas and FasL to erythropoiesis in the adult. We bred lpr or gld
mice, mutant in Fas and FasL respectively, onto the Rag12/2
immune-deficient background, in order to avoid an autoimmune
syndrome that may impact erythropoiesis. Our findings in both
the lpr-Rag12/2 and gld-Rag12/2 mice were similar, showing that
Fas-mediated autoregulation in spleen negatively regulates eryth-
ropoiesis at the whole animal level. Strikingly, these experiments
also revealed that Fas-mediated autoregulation imparted key
dynamic properties to the erythropoietic system. We found that it
Figure 1. Epo regulation of erythropoiesis through Fas-mediated apoptosis. (A) Epo-dependent erythroblastic island precursors CFU-e,
ProE and EryA (in blue) co-express Fas and FasL, and mature into Epo-independent EryB, EryC and red blood cells (RBC, in red). ‘F’ = Fas expressing
cells, shown undergoing cell death as a result of interaction with FasL-expressing cells within the Epo- dependent (blue) compartment (black flat-
headed arrow). A negative feedback loop driven by tissue pO2 regulates Epo levels in blood, which in turn enhance erythroblast survival, by either
suppressing Fas and FasL expression, or by non-Fas dependent pathways. HSC = hematopoietic stem cells. (B) Flow-cytometric identification of Epo-
dependent ProE and EryA subsets (in blue) and Epo-independent EryB and EryC (in red), in adult Balb/C mouse spleen, in basal conditions (top
panels) or 48 hours following Epo injection (300 U/ mouse, lower panels). ProE are defined as Ter119medCD71high cells; Ter119high cells are further
subdivided based on forward scatter (FSC) and CD71 expression into EryA (CD71highTer119highFSChigh), EryB (CD71highTer119highFSClow) and EryC
(CD71lowTer119highFSClow). (C) The erythropoietic response of mice to a hypoxic environment. Mice (Balb/C) were examined either in the basal state
(‘a’, 21% atmospheric oxygen), when housed in 11% oxygen for 8 days (assay times ‘b’ and ‘c’ at 13 hours and 3 days, respectively), and when placed
back in normoxia (21%; assay times ‘d’ and ‘e’, at 1 and 2 days post-hypoxia). Top panels show representative flow-cytometric histograms of Fas
expression and Annexin V binding at the indicated assay times. Gates refer to the Fas+ and Annexin V+ populations, determined with reference to
staining controls in which either the anti-Fas antibody (left panel) or Annexin V (right panel) were omitted. The fraction of cells positive for Fas or
Annexin V at each time point is noted. Middle panel shows a summary of similar data, 2 to 9 mice per time point. Lower panels show corresponding
serum Epo levels and EryA cell number in spleen (expressed as total EryA cells /gram body weight). *p,0.05, **p,0.002, ***p,0.0001 (two-tailed
t test, unequal variance).
doi:10.1371/journal.pone.0021192.g001
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is responsible for stabilizing the basal precursor pool, enhancing
their resistance to random perturbations. Further, it also
accelerated the erythropoietic response to high Epo, an unexpect-
ed effect for a negative regulator. Therefore, the dynamic
properties of the Fas-mediated autoregulation offset the dynamic
deficits of the slower, pO2/Epo-regulated feedback. Of interest,
negative autoregulatory loops, in the context of simple transcrip-
tional networks, were shown to accelerate the response to a
stimulus, and to enhance network stability [32,33,34,35]. Our
findings here suggest that these loops, which are abundant in
biological systems, similarly improve the homeostasis and dynamic
responses of lineage-specific progenitors in vivo.
Materials and Methods
Please also see Text S1: Supplementary Material and Methods
section.
Mice
B6.MRL-Faslpr/J (Jackson Laboratories stock # 000482) were
crossed with B6.129S7-Rag1tm1Mom/J (stock # 002216) to obtain
homozygous double-mutant lpr-Rag12/2 mice (C57BL/6J back-
ground). The homozygous double mutant gld-Rag12/2 mice (Balb/
C background) were obtained by crossing CPt.C3-Faslgld/J (Jackson
Laboratories, stock # 002932) with C.129S7(B6)-Rag1tm1Mom/J
(Jackson Laboratories stock # 003145). Other Balb/C mice for the
hypoxia chamber experiments were purchased from Taconic. All
experiments were approved by the University of Massachusetts
Medical School IACUC committee, under protocol number A1586.
Flow cytometry. Flow cytometry was performed as described
[12] on freshly isolated spleen and bone-marrow cells. Dead cells
were excluded using DAPI (Roche, Indianapolis, IN) or 7-AAD
(BD Biosciences) viability dye. Data were analyzed using FlowJo
software (Tree Star, Ashland, OR).
Statistical analyses. Statistical analyses was performed using
PASW (SPSS, Chicago, IL) and SAS (SAS, Cary, NC) statistical
software. Data was log-transformed and analyzed by general linear
mixed model ANOVA with gender and genotype as fixed effects
and experiment as the random effect. Unadjusted p-values were
reported in the figures for each gender-genotype group.
Results
Hypoxia and return to normoxia alter Fas expression and
survival of early erythroblasts
Erythropoietic stress results in suppression of Fas expression and
reduced apoptosis in splenic ProE and EryA [12]. These findings
suggested the model illustrated in Figure 1A, in which Fas-
mediated cell death is a result of intercellular interactions between
Fas and FasL-co-expressing cells within the spleen early erythro-
blast compartment; these interactions are blocked by high Epo
during stress (Fig 1B).
Here we investigated this model further by housing mice in a
hypoxic environment of 11% oxygen for 8 days, followed by a
return to normoxia (21% oxygen). Hypoxia caused a sharp
increase in plasma Epo (Fig 1C, lower left panel), suppressing Fas
expression in EryA and enhancing their survival (Fig 1C, upper
panel: example of flow-cytometric measurements of Fas expression
and Annexin V binding; middle panels: summary of data form 2 to
9 mice per time point). Decreased apoptosis and Fas expression
were associated with increased spleen EryA (Fig 1C, lower right
panel). A return to 21% oxygen resulted in a rapid reversal, with
Epo and EryA declining below their starting levels, and both Fas
expression and apoptosis rising well above their starting basal
levels. These results suggest that modulation of Fas-mediated
apoptosis by Epo plays a role in both the expansion of the EryA
pool in response to hypoxia, and in its rapid contraction with the
return to normoxia.
Effect of reducing Fas-mediated apoptosis with Fas:Fc
in vivo
To examine the effect of Fas on EryA survival directly, we
administered MyD882/2 mice with the purified chimeric
molecule, Fas:Fc [36], which acts as a decoy receptor, binding
FasL on the surface of EryA and blocking its ability to activate Fas.
Control MyD882/2 mice were injected intraperitoneally with an
equal volume of saline. The MyD882/2 strain was used in order
to avoid potential reaction to contaminating bacterial Lipopoly-
saccharide (LPS) in the Fas:Fc preparation [37]. A single
administration of Fas:Fc (100 mg) resulted in a 20% reduction in
unoccupied surface FasL in both splenic ProE and EryA,
measured by binding of the Fas-blocking monoclonal antibody
MFL3, directed against FasL [38] (not shown). This procedure
decreased the number of Annexin V+ EryA from 70% in control to
50% in Fas:Fc -injected mice by 48 hours. There was an
associated increase in EryA, and a doubling in blood reticulocytes
(Fig S1). Reticulocytes, identified by their RNA content, mature
within 24 hours [39]; a doubling of reticulocytes suggests a
doubling of erythropoietic rate over the most recent 24 hours.
These results support a causal relationship between Fas expression,
EryA survival and erythropoietic rate.
The dose/response characteristics of Epo-mediated Fas
suppression and EryA expansion
To assess the quantitative relationship between Epo, Fas
suppression and EryA numbers we injected mice (n = 38) with
varying doses of Epo, of between 1 and 300 Units /25 g body
weight. We measured the Fas response on day 3, previously found
to correspond to the lowest Fas expression level attained following
acute Epo injection [12]. We found that EryA frequency in
Ter119+ spleen cells was inversely related to the fraction of EryA
cells that expressed Fas (Fig 2A, left panel). Half maximal
suppression of Fas expression was seen in mice injected with
10 U/25 g (Fig 2A, right panel), corresponding to a doubling of
EryA frequency. Complete suppression of Fas expression was seen
at 30 U/ 25 g, and resulted in a 6-fold increase in EryA frequency.
The frequency of EryA is inversely related to their Fas
expression
The relationship between EryA frequency, and the fraction of
EryA that express Fas, may be fitted by a model in which EryA
undergo Fas-mediated negative autoregulation (Fig 2B). We
considered the frequency of EryA within the erythroblastic island,
‘A’, to be the result of three principal factors: first, a continuous
input from earlier progenitors, ‘ß’; second, a continuous output,
proportional to A,’aA’, into more differentiated progenitor subsets;
and last, Fas-dependent cell death. We assumed that Fas-mediated
cell loss would result when two EryA cells, expressing Fas and FasL
respectively, interact within the erythroid compartment. The
probability of such an encounter is proportional to the product of
the frequencies of Fas+ and FasL+ EryA cells. This product is
approximately equal to A2F, where ‘F’ denote the fraction of EryA
cells that express Fas (Fig 2B; the fraction of EryA that express
FasL in adult spleen is high enough that it can be approximated to
1; see Text S2: ‘Regulation of the EryA progenitor pool by Fas’).
These considerations allow the steady-state level of EryA, at any
given level of Fas, to be found by solving a quadratic equation.
Fas Stabilizes and Accelerates Erythropoiesis
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The inverse relationship between EryA and Fas in Fig 2A is fitted
well by a hyperbolic curve that represents the (positive) steady-state
solutions for EryA (‘A’) in this equation, at different steady-state
levels of Fas (‘F’) (R2 = 0.89, Text S2). This goodness of fit supports
the model’s key assumption, that Fas-mediated cell loss is a result
of negative autoregulation within the EryA pool, and is
proportional to the square of the frequency of EryA within the
erythroblastic island. Further, it suggests that Epo concentration,
which sets the desired steady-state EryA pool size, does so in part
by regulating the level of Fas expression in the EryA population
(Fig 1A).
Of note, using a different modeling approach, we found a
similar relationship in fetal liver, where Fas-mediated loss of early
erythroblasts was proportional to the square of the frequency of
early erythroblasts in the tissue [31].
Generation of Fas and FasL-deficient mice on an
immune-deficient background
We made use of the lpr and gld mouse strains that carry
naturally-occurring loss-of-function mutations of Fas and FasL,
respectively [40]. The lpr mutation consists of an insertion of an
early transposable element, carrying a polyadenylation signal, in
the second intron of the Fas gene. This causes premature
termination of the transcript and a drastic decrease in Fas
transcription, though it does not fully eliminate it. In the gld strain,
there is a point mutation at the C-terminus of FasL that abolishes
its ability to bind Fas. Both the lpr and gld mice develop a lymphoid
proliferative autoimmune syndrome [41]. In order to avoid this
complication, we bred these mouse strains onto an immune-
deficient, Rag12/2 background that lacks T and B cells [42].
Erythroid parameters, such as basal hemoglobin concentration,
though consistent within a given inbred strain, differ somewhat
between mice of different genetic backgrounds, likely reflecting
quantitative differences in the control of erythropoiesis [43]. We
therefore chose to generate two distinct genetic background
strains. The gld-Rag12/2 mice were bred on the Balb/C
background, and the lpr-Rag12/2 mice on the C57BL/6
background. As controls, we used age and strain-matched
Rag12/2 mice, which on either the Balb/C or the C57BL/6
backgrounds, have normal erythropoietic parameters when
compared with wild-type mice of the same background strain.
Further, the double homozygous mutant strains, gld-Rag12/2 and
lpr-Rag12/2, showed no sign of autoimmunity, as evident from
their small spleen size, absence of immune cells from the blood and
spleen, and lack of anemia (Table S1 and data not shown).
Basal Erythropoiesis in lpr-Rag12/2 and gld-Rag12/2
mice
The chronic absence of an erythropoietic regulator may not be
apparent from simple inspection of the hematocrit in the steady
state [20]. This is due to a vast erythropoietic reserve, coupled with
the pO2/Epo negative feedback loop which automatically adjusts
Epo levels and erythropoietic rate so as to maintain a near- normal
tissue pO2. Therefore, to assess how the loss of a regulator affects
steady state erythropoiesis requires analysis at all levels of the
pO2/Epo negative feedback loop, including Epo concentration
Figure 2. Fas and FasL-mediated negative autoregulation of the EryA pool. (A) Wild-type Balb/C mice were injected with a single Epo
injection subcutaneously, of 1, 3, 6, 10, 30, 100 or 300 U/ 25 g body weight. Spleen EryA were examined on day 3 post injection. Left panel shows
EryA cell frequency relative to basal frequency, plotted against the number of EryA cells that express Fas (Fas+ EryA, expressed as a ratio to basal
levels). Data points represent individual mice. Blue =mice in the basal state (n = 15), red =mice injected with Epo (n = 38). For clarity only mice
injected with 30 U (which maximally suppress Fas) or less are included in the left panel. Data is fitted with a curve derived from the mathematical
model described in panel (B) and in the Text S2. Right panel shows the dependence of Fas+ EryA on the dose of injected Epo, in the same dataset as
in the left panel; all mice injected with a given Epo dose were pooled into one data point, mean6 sem. (B) Schematic of the factors that regulate the
size of the EryA pool, ‘A’, measured as the fraction of all Ter119+ cells that are EryA. F = fraction of EryA cells that express Fas. ß = input into the EryA
pool from earlier progenitor stages. aA =output from the EryA pool into later erythroid subsets (EryB). A2F = Fas-mediated cell loss. See
mathematical model described in Text S2. In panel (A) of this figure, A is plotted against F, expressed as a ratio to the A and F values in the basal state,
respectively.
doi:10.1371/journal.pone.0021192.g002
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and the erythroid progenitor and precursor pools. We first
examined the hematocrit (the fraction of all blood volume that is
attributable to red blood cells), blood reticulocytes and plasma
Epo. lpr-Rag12/2 mice on the C57BL/6 background had a
normal reticulocyte count and normal hematocrit (Figure 3A, top
left panel, Table S1). However, plasma Epo was significantly
lower, by 35%, than in control mice (p = 0.001; Epo=
9.060.8 mU/ml, mean 6sem, in lpr-Rag12/2, and 13.761.0
for Rag12/2 controls; Fig 3A, bottom left panel, and Fig 3B).
Therefore, lpr-Rag12/2 mice compensate for the chronic absence
of a negative regulator through the pO2/Epo negative feedback
loop, decreasing Epo concentration so as to avoid an unnecessary
increase in hematocrit.
By contrast, the gld-Rag12/2 mice, on the Balb/C background,
had a significantly elevated hematocrit (p,0.00001; hematocrit =
52.060.3% vs. 49.860.4% for gld-Rag12/2 vs. Rag12/2 respec-
tively, mean6sem, Figures 3A; a similar difference was found in a
second group of mice assayed using a Coulter counter, Table S1).
Reticulocyte count was also more than double that of con-
trols (p,0.0001; Reticulocyte count = 1.4060.14% vs. 0.596
0.04% for gld-Rag12/2 vs. Rag12/2 respectively, Fig 3C–D), and
hemoglobin concentration was also significantly elevated in 2
independent experiments (Table S1). As comparison, mice we
housed for 3 weeks in 12% oxygen, equivalent to an altitude of
14,000 feet, increased their hematocrit from 51.660.2 to
57.860.5%, an increase of 6%. Therefore, the 2.2% increase in
Figure 3. Increased erythropoiesis in mice deficient in the Fas pathway. Legend in A also applies to panels B, D. lpr-Rag12/2 mice are on
the C57BL/6 background (in blue), and are compared with control Rag12/2 mice on the C57BL/6 background. gld-Rag12/2 mice are on the Balb/C
background (in red), and are compared with control Rag12/2 mice on the Balb/C background. (A) Hematocrit ( = fraction of the blood volume that is
due to red cells) and Plasma Epo of lpr-Rag12/2, gld-Rag12/2 and Rag12/2 age and strain-matched control mice. M= males. F = females. Box and
whiskers delineate the central 50% and 90% of readings, respectively. Median is indicated with a horizontal line; arithmetic mean with a ‘+’. Data
points correspond to individual mice. Between 11 and 40 mice examined per genotype. *p,0.05, **p,.005, ***p,0005 (ANOVA). (B) Hematocrit vs.
plasma Epo in the subset of mice where both values were measured, in the basal state, for lpr-Rag12/2 and matched Rag12/2 control mice (left
panel), and for gld-Rag12/2 and matched Rag12/2 controls (right panel). Data are mean 6 sem of $16 mice *p#0.001 (two-tailed t test, unequal
variance). (C) Flow cytometric measurement of reticulocyte number. Top: whole blood stained with either DRAQ5 (detects DNA) or thiazole orange
(TO, detects both DNA and RNA). Reticulocytes lack a nucleus but retain RNA. They therefore form a DRAQ5-negative, TO-positive population. Bottom
panel shows analysis in wild-type (WT) mice either in the basal state or following Epo injection; and in gld-Rag12/2 and control Rag12/2 mice. (D)
Reticulocyte in lpr-Rag12/2, gld-Rag12/2 and matched Rag12/2 controls, measured by flow-cytometry ***p,0.0001, two-tailed t-test, unequal
variance; ff = p,0.001, F test.
doi:10.1371/journal.pone.0021192.g003
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hematocrit in the gld-Rag12/2 mice represents approximately a
third of the erythropoietic output in high altitude hypoxia. Unlike
the lpr-Rag12/2, plasma Epo in the gld-Rag12/2 mice was not
significantly different to that of controls (Fig 3A), possibly because
of the already low basal Epo in control Balb/C mice which was
,40% lower than in control mice on the C57BL/6 background
(Fig 3A, lower panels, black symbols).
Of note, responses by both gld-Rag12/2 (Balb/C background)
and the lpr-Rag12/2 (C57BL/6 background) mice have in
common a higher erythropoietic rate per unit plasma Epo than
in matched control mice, consistent with the absence of a negative
regulator of erythropoiesis.
Increased splenic CFU-e, ProE and EryA in gld-Rag12/2
and lpr-Rag12/2 mice
A representative flow-cytometric histogram in Figure 4A shows
that the frequency of the ProE and EryA subsets within gld-
Rag12/2 spleen erythropoietic tissue (Ter119+ cells) was
increased. A similar analysis in 11 to 40 mice per strain/sex
combination is summarized in Figures 4B and 4D. An increase in
subset frequency does not necessarily reflect a corresponding
increase in cell number, since it may also arise as a result of
decreased cell number in other subsets. We therefore also
examined the absolute number of cells in each of the erythroid
precursor subsets, computed by multiplying the subset frequency
Figure 4. Increased frequency of spleen, but not bone-marrow, erythroid progenitors and precursors in mice deficient in the Fas
pathway. The Legend in panel B also applies to C,D. (A) Representative flow-cytometric analysis of spleen erythroid subsets in gld-Rag12/2 and
matched Rag12/2 controls, showing increased frequency of ProE and EryA within Ter119+ cells. (B) Frequency of erythroblast subsets in spleen
erythropoietic tissue, measured as in A, expressed as fraction of all spleen Ter119+ cells. F = female M=male. Box and whiskers delineate the central
50% and 95% of readings, respectively, with the median indicated with a horizontal line and arithmetic mean with a ‘+’. Data points are individual
mice (11–40 mice per sex/genotype combination). Data was pooled from several independent experiments. (C) CFU-e progenitors in spleen and
bone-marrow. Data pooled from two independent experiments for females, and one experiment for males, for each genotype. (D) Frequency of
erythroblast subsets in bone-marrow expressed as fraction of all spleen Ter119+ cells. For all panels, *p,0.05 **p,0.02, ***p,0.002 (ANOVA, for
difference in means). f=p,0.05 ,ff=p,0.02, fff=p,0.002 (F test, for difference in variance).
doi:10.1371/journal.pone.0021192.g004
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data by the fraction of Ter119+ cells per spleen and the spleen
weight, for each individual mouse (Fig 5A).
These data show significant increases, ranging from 1.5 to 4-
fold, depending on genotype and sex, in both the frequency and
absolute number of spleen CFU-e, ProE, EryA and EryB, in gld-
Rag12/2 and lpr-Rag12/2 mice (Figures 4A–C and 5A).
Specifically, all the splenic ProE, EryA and EryB subsets showed
increased frequency within the Ter119high compartment in both
gld-Rag12/2 and lpr-Rag12/2 mice relative to matched controls,
with this increase reaching statistical significance in ten of the
twelve comparisons made, namely ProE (p,0.02), EryA
(p,0.002) and EryB (p,0.002) in female lpr-Rag12/2 mice, ProE
(p,0.002), EryA (p,0.002) and EryB (p,0.02) in male lpr-
Rag12/2 mice, ProE (p,0.02), EryA (p,0.02) and EryB (p,0.02)
in female gld-Rag12/2 mice, and EryB (p,0.02) in male gld-
Rag12/2 mice. The frequency of ProE and EryA in male gld-
Rag12/2 mice was also increased relative to controls but did not
reach statistical significance. Similarly, the absolute number of
cells in each of these erythroid subsets increased in both gld-
Rag12/2 and lpr-Rag12/2 mice, reaching significance in nine of
the twelve comparisons made, namely, ProE (p,0.005), EryA
(p,0.0005) and EryB (p,0.0005) in female lpr-Rag12/2 mice,
ProE (p,0.0005), EryA (p,0.0005) and EryB (p,0.05) in male
lpr-Rag12/2 mice, and ProE (p,0.05), EryA (p,0.005) and EryB
(p,0.05) in female gld-Rag12/2 mice. The number of ProE, EryA
and EryB in male gld-Rag12/2 mice also increased but the
differences did not reach statistical significance (Fig 5A). The
number of gld-Rag12/2 mice available for analysis was smaller
than that of the other sex/strain combinations (Fig 4B, 5C),
possibly accounting for the failure of the change in their
erythroblast subsets to reach statistical significance.
Of note, there was no significant change in any of the equivalent
subsets in bone-marrow (Fig 4D) for any sex/strain combination.
These results are consistent with the pattern of erythroid Fas and
FasL co-expression, which is largely restricted to spleen [12]. The
largest increases were observed in ProE and EryA, in agreement
with their higher Fas and FasL expression [12].
Variability in basal erythropoietic rate and in the size of
spelnic erythroid subsets in gld-Rag12/2 and lpr-Rag12/2
mice
Whilst the mean size of the ProE and EryA pools increased in
gld-Rag12/2 and lpr-Rag12/2 mouse populations, their actual size
in individual mice was highly variable. Using an F-test we found
significantly higher variance in both the frequency and absolute
number of nearly all erythroblast subsets in the gld-Rag12/2 and
lpr-Rag12/2 mice, and in gld-Rag12/2 reticulocytes, compared
with matched Rag12/2 controls (significantly different variance is
marked with an ‘f’; Figures 3D, 4B–C, 5A). The EryA frequency
distributions (Figures 5B and S2) show the larger spread of EryA
pool size in the mutant mice. We also found increased coefficient
of variation (CV) for EryA and ProE in male, but less so in female,
gld-Rag12/2 and lpr-Rag12/2 mice (Figures 5B and S2). The
coefficient of variation measures variability independently of the
Figure 5. Loss of Fas function results in a larger and more variable basal spleen erythroid progenitor pool. (A) Spleen erythroid subsets
ProE, EryA or EryB, expressed as absolute number of cells per gram body weight, in gld-Rag12/2, lpr-Rag12/2 and matched Rag12/2 controls, shown
separately for male (M) and female (F) mice. Data corresponds to the same mouse dataset as in Fig 4. Box and whiskers delineate the central 50% and
90% of readings, respectively, with the median indicated with a horizontal line and arithmetic mean with a ‘+’. Data points correspond to individual
mice. Between 11 and 40 mice examined per genotype; data pooled from several independent experiments. *p,0.05, **p,0.005, ***p,0.0005
(ANOVA, for difference in means); f=p,0.05, ff=p,0.005, fff=p,0.0005 (F test, for difference in variance). (B) Frequency distribution histograms for
EryA, in male and female lpr-Rag12/2 and matched Rag12/2 controls. The coefficient of variation for each group is shown. Purple line is the fitted
normal distribution curve. Same data set as in panel (A).
doi:10.1371/journal.pone.0021192.g005
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population mean. Overall, CV values for all splenic erythroblast
subsets and for peripheral blood reticulocytes in both gld-Rag12/2
and lpr-Rag12/2 male and female mice, are significantly increased
(p = 0.017, Figure S2 B). These findings indicate that a key
function of Fas-mediated negative autoregulation is to suppress
variability in the steady-state precursor pool and in erythropoietic
rate, thus stabilizing the basal state.
A delayed response to Epo-driven erythropoietic stress in
gld-Rag12/2 and lpr-Rag12/2 mice
We took two approaches to assess the stress response of the gld-
Rag12/2 and lpr-Rag12/2 mice. First, we injected mice with a
single high dose of Epo (300 U/ 25 g body weight), and followed
the resulting increase in erythropoietic rate for 6 days (Fig 6A–D).
Initially, on days 1 and/or 2, hematocrit was higher in both gld-
Rag12/2 and lpr-Rag12/2 mice compared with controls, by 1–
2%, possibly reflecting the larger basal erythroblast pool in these
mice. However, between days 2 and 3, there was a significantly
faster increase in hematocrit in control mice, which rose by over
4% in the space of 24 hours, overtaking the hematocrit of gld-
Rag12/2 and lpr-Rag12/2 mice (Fig 6A, 6D). There was no
equivalent rapid increase in hematocrit in the gld-Rag12/2 and
lpr-Rag12/2 mice. By subtracting the mean hematocrit on day 2
from the mean hematocrit on day 3, in 5 independent
comparisons between independent experiments on those days,
we found that the rate of change in the hematocrit was
significantly higher in control mice (p,0.005, Fig 6D). The slower
increase in hematocrit in both gld-Rag12/2 and lpr-Rag12/2 mice
at this time was due to a slower expansion of EryA precursors, in
spite of their larger basal EryA pools (Fig 6B, 6C). The difference
in EryA expansion was largest on days 2 (lpr-Rag12/2 mice) and 3
(gld-Rag12/2mice) (Fig 6C), corresponding to the time when Epo-
mediated Fas suppression in wild-type mice reaches its peak [12].
Of note, EryA expansion in control mice was a massive, 30 to
60 fold increase over the basal EryA pool. The shortfall in EryA on
day 2 in the lpr-Rag12/2 mice was equivalent to 10 times the size
of the basal EryA pool, or 30% of the total expansion in control
mice on that day (Figure 6B,C, p,0.05; the size of the basal EryA
pool is marked Fig 6C as a black bar). A similar delay in EryA
expansion was seen in gld-Rag12/2 mice (Figure 6B,C). Further,
injection of a much lower Epo dose (10 U/ 25 g body weight) in
lpr-Rag12/2 mice again resulted in delayed hematocrit and ProE
responses (Fig S3). Therefore, the presence of Fas-mediated
negative autoregulation accelerates the erythropoietic response
over a wide Epo stress range.
Analysis of changes in the ProE population showed similar
results. In spite of its larger size in the basal state, expansion of the
ProE pool in both gld-Rag12/2 and lpr-Rag12/2 mice was slower
between days 1 and 3, the differences in the absolute size of the
pools reaching significance on days 1 (gld-Rag12/2 mice) and 3
(lpr-Rag12/2 mice) (Fig 7A). Furthermore, the rate of increase in
ProE in response to Epo peaked in all mice between days 1 and 2,
attaining a significantly lower level in gld-Rag12/2 and lpr-Rag12/
2 mice compared with matched controls (p = 0.00004, Fig 7 B,C).
A delayed erythropoietic stress response to reduced
atmospheric oxygen in gld-Rag12/2 mice
In a second approach, we examined the response of the gld-
Rag12/2 mice to an acute reduction of atmospheric oxygen to
11% (Fig 8). The response to reduced atmospheric oxygen is
complex since, in addition to elevating serum Epo, it stimulates
additional cytokines as well as changes in ventilation and plasma
volume that may indirectly alter erythropoietic responses
[8,44,45]. Furthermore, the actual increase in serum Epo in
response to lower atmospheric oxygen is determined not only by
the initial hypoxic stimulus, but also by the ensuing erythropoietic
response, which determines the duration of tissue hypoxia (Fig 1A).
We chose to examine gld-Rag12/2 mice, since, unlike the lpr-
Rag12/2 strain, their starting baseline Epo levels are very similar
to those of their matched controls (Fig 3B). We found that in spite
of their higher starting hematocrit and reticulocyte count, the
increase in erythropoietic rate in gld-Rag12/2 mice was
significantly slower, as seen by a significantly delayed increase in
hematocrit (Fig 8A) and a lower reticulocyte count (Fig 8B). There
was a correspondingly slower increase in EryC erythroblasts
(Fig 8D), at both 24 and 72 hours. This sluggish response
presumably prolonged the tissue hypoxia in these mice, as
reflected by their higher serum Epo at 72 hours (Fig 8C). These
results clearly show a delayed stress response in mice lacking Fas-
mediated negative autoregulation of erythroblasts.
Unlike the response to injection of a fixed, high Epo dose (Fig 6),
the slower erythropoietic response to hypoxia in the gld-Rag12/2
mice was not associated with a difference in the size of the ProE/
EryA pools at the early (24 hour) time point. Such a difference
may have occurred earlier; alternatively, hypoxia may accelerate
the maturation of EryA cells, so that reserve, Fas+ EryA cells in
control mice do not contribute to an increase in the EryA pool but
instead differentiate rapidly and contribute to the increase that we
see in the EryC pool by 24 hours (Fig 8D). Indeed, it has been
observed previously that hypoxic stress as a result of bleeding or
phehylhydrazine stress accelerates erythroblast maturation
[46,47,48]. The larger number of EryA in gld-Rag12/2 by
72 hours presumably reflects the higher Epo level at that time, in
turn a result of the more prolonged stress these mice presumably
experience, due to their sluggish erythropoietic response to the
initial hypoxic stimulus.
Discussion
We investigated the role of Fas and FasL-mediated negative
autoregulation in the early erythroblast pool. We generated gld-
Rag12/2 and lpr-Rag12/2 mouse strains, deficient in FasL and
Fas, respectively, bred onto two distinct genetic backgrounds. Both
these strains showed similar erythropoietic deficits. They confirm
the hypothesis that Fas and FasL are negative regulators of splenic
EryA and ProE, resulting in negative regulation of erythropoiesis
at the whole animal level. In addition, they show a striking, non-
redundant role for Fas in stabilizing basal erythropoiesis.
Surprisingly, in spite of the removal of a negative regulator and
the consequent larger basal precursor pool, the response of the
mutant mice to erythropoietic stress was significantly delayed.
These findings reveal that an autoregulatory loop local to
erythropoietic tissue can exert key dynamic properties on
erythropoiesis as a whole. They also provide experimental
evidence that regulation of erythroid precursors through apoptosis,
though apparently wasteful, accelerates the response to erythro-
poietic stress.
The presence of a local negative autoregulatory loop in
spleen erythropoietic tissue
Several lines of evidence suggest that EryA and ProE negatively
regulate their own survival through their Fas and FasL-mediated
interactions. First, the pattern of co-expression of both Fas and
FasL by EryA and ProE [12,31]; second, the close apposition of
cells within the erythroblastic island, making an interaction
between Fas+ and FasL+ cells possible [31]; and last, our finding
that a mathematical model in which EryA negatively regulate their
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own survival via the Fas/FasL interaction, accounts well for the
experimental data correlating splenic EryA frequency with their
Fas expression, across a wide range of Epo concentrations in vivo
(Fig 2 and Text S2).
Fas-mediated negative autoregulation decreases
erythropoiesis at the whole-animal level
Both acute and chronic inhibition of Fas suggest that it
negatively regulates erythropoiesis at the level of the whole
Figure 6. Delayed response to Epo-induced stress in mice deficient in the Fas pathway. (A–D) gld-Rag12/2, lpr-Rag12/2 and matched
Rag12/2 control mice were injected with Epo (300 U/ 25 g body weight) subcutaneously at t = 0. The erythropoietic response was followed for 6
days. Data is mean 6 sem for 3 to 18 mice per time point per genotype, pooled from up to 3 experiments per time point. Data at t = 0 is the basal
state data shown in Figures 3A and 5A, pooled for males and females. (A) Hematocrit measurements (B) Spleen EryA (cells per gram body weight) in
the same mouse set as in the top panel. Data points are individual mice, with the mean 6sem for each day marked as a horizontal line. (D) The
difference in mean EryA number (shown in panel B) between the mutant gld-Rag12/2 or lpr-Rag12/2 and their matched Rag12/2 controls, for each
day. The size of the corresponding control (Rag12/2) EryA pool is marked with a black bar. For all panels: *p,0.05, **p,0.005, ***p,0.0005 (t test,
unequal variance). (D) The rate of change in hematocrit between days 2 and 3 following Epo injection. The same dataset as in panel (A), showing the
differences in hematocrit measured in multiple independent experiments on days 2 and 3. Altogether 5 independent comparisons are shown. For all
panels: *p,0.05, **p,0.005, ***p,0.0005 (t test, unequal variance).
doi:10.1371/journal.pone.0021192.g006
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animal. An acute decrease in erythroblast FasL by transient
administration of the decoy receptor Fas:Fc resulted in an acute
increase in erythropoietic rate, reducing ProE and EryA apoptosis
and doubling reticulocyte number by 48–72 hours (Fig S1).
Chronic loss of Fas function in the gld-Rag12/2 and lpr-Rag12/2
mice is likely to elicit compensation through the pO2/Epo-mediated
negative feedback loop, which automatically adjusts Epo levels and
erythropoietic rate so as to maintain a near-normal basal hematocrit
and tissue pO2. Alhough lpr-Rag1
2/2 mice had normal reticulo-
cytes and hematocrit, their plasma Epo was significantly lower, by
35%, than in matched Rag12/2 controls, evidence of compensa-
tory adjustment. By contrast, gld-Rag12/2 mice were apparently
unable to significantly lower their already low plasma Epo.
Consequently, their reticulocyte numbers in peripheral blood, a
direct measure of erythropoietic rate, more than doubled, and there
was a corresponding significant 2.2% increase in hematocrit. This
increase is equivalent to a third of the increase in hematocrit we
observed in mice housed in 12% oxygen, equivalent to hypoxia at
14,000 feet.
While many pathways have been implicated in the regulation of
erythropoietic rate, a specific contribution to the stress response in
vivo had been determined for very few. Of note, mice lacking
ERK1, a recently described negative regulator of splenic
erythropoiesis, showed a similar increase in hematocrit to that
seen here for the gld-Rag12/2 mice, without a significant change
in plasma Epo [49]. Taken together, both the lpr-Rag12/2 and
gld-Rag12/2 strains show increased erythropoietic rate per unit
plasma Epo when compared with matched controls, confirming
that local negative regulation at the level of splenic erythropoietic
tissue has a negative effect at the level of the whole animal.
There is no indication that Fas and FasL interact with
alternative receptors or ligands. Therefore, the difference in the
response of the gld-Rag12/2 and lpr-Rag12/2 mice at the level of
the hematocrit and serum Epo is likely attributable to their
different genetic backgrounds. The response of both these mouse
strains at the level of the ProE and EryA precursors, the direct sites
of action of Fas and FasL, was very similar.
Loss of Fas function results in a specific increase of
spleen ProE and EryA pools
We found a significant 1.5 to 4 fold increase in the number of
splenic, but not bone-marrow, ProE and EryA in both the gld-
Rag12/2 and lpr-Rag12/2 mice, consistent with the pattern of
erythroid Fas and FasL expression[12]. We also identified an
increase in CFU-e specific to spleen, suggesting that these cells are
regulated by Fas, in agreement with their counterpart in fetal liver
[31]. Bone marrow progenitor subsets were either normal or even
decreased in number, possibly as a compensatory response to their
increase in spleen (Fig 4C,D).
Figure 7. Delayed response to Epo-induced stress in mice deficient in the Fas pathway. (A–C) Analysis of the ProE response to Epo
injection. The same experiment and dataset as in Figure 6. (A) Spleen ProE (cells per gram body weight). Data points are individual mice, with the
mean6sem for each day marked as a horizontal line. Data pooled from 1 to 3 experiments with 3 to 18 mice per genotype. (B) The rate of change in
spleen ProE between days 1 and 2 post-Epo injection in the mutant gld-Rag12/2 (indicated in red) or lpr-Rag12/2 (blue) and their matched Rag12/2
controls. Dataset as in panel (A). Each point represents the mean difference in ProE between independent experiments done on days 2 and 3, in 5
independent comparisons. (C) The rate of change in spleen ProE throughout the first 3 days of response to Epo, computed as in panel B. The rate of
change between days 0 and 1, days 1 and 2, and days 2 and 3, were plotted on days 0.5, 1.5 and 2.5, respectively. Data points represent pooled
mutant (lpr/gld) or control differences (mean 6sem). For all panels: *p,0.05, **p,0.005, ***p,0.0005 (t test, unequal variance).
doi:10.1371/journal.pone.0021192.g007
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The increase in spleen ProE, EryA and CFU-e is due to the
absence of a spleen-specific negative regulator, rather than
erythropoietic stress, since it is not associated with elevated serum
Epo, and since there is no associated increase of bone-marrow
progenitors. It is unlikely that the increase in ProE/EryA is a
consequence of expansion in an earlier, Fas-regulated progenitor
compartment, since there was no significant change in bone-
marrow erythroid progenitors, platelets or white cells (Table S1).
An earlier report of increased CFU-S in adult lpr and gld mice [50]
is complicated by the autoimmune syndrome in these mice, which
in the present work we addressed by breeding the lpr and gld
mutant mice onto the immune-deficient Rag12/2 background.
The expansion in ProE and EryA precursor pools in the gld-
Rag12/2 and lpr-Rag12/2 mice represents a substantial non-
redundant negative regulatory function of Fas. Nevertheless, it is
likely to be an underestimate of the actual number of ProE/EryA
that are regulated by Fas in wild-type mice, as suggested by the
response to stress (see below). Compensatory mechanisms that
Figure 8. Delayed response to hypoxia-induced stress in mice deficient in the Fas pathway. (A–D) gld-Rag12/2 or control mice were
transferred to a hypoxia chamber with ambient 11% oxygen for 1 or 3 days. Data is mean 6sem for 4 to 9 age and gender-matched mice per time
point per genotype. Data at t = 0 is the basal state data shown in Figures 3A and 5A, pooled for males and females. (A) Hematocrit measurements,
performed via CritSpin microcentrifugation. (B) Reticulocyte measurements, performed flow cytometrically, as in Figure 3C. (C) Plasma Epo, measured
by ELISA. (D) Spleen erythroid subsets ProE, EryA, EryB and EryC, expressed as absolute number of cells per gram body weight in gld-Rag12/2 and
matched Rag12/2 controls. For all panels: *p,0.05, **p,0.005, ***p,0.0005 (t test, unequal variance).
doi:10.1371/journal.pone.0021192.g008
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could ameliorate the absence of Fas or FasL include upregulation
of alternative negative regulators such as ERK1 [49], attenuation
of alternative EpoR anti-apoptotic pathways such as Stat5-induced
bcl-xL, phosphoinositol-3 kinase/AKT and suppression of Bim
and Foxo3a [17,24,51], or a decrease in factors that stimulate
erythropoiesis such as BMP [52].
A stabilizing function for the Fas and FasL-mediated
negative autoregulatory loop
Random variation in the number of progenitors is an inevitable
consequence of inherent fluctuations in biological systems
[53,54,55], found in mice that are genetically identical, of similar
age and housed in similar stable conditions. The pO2/Epo-
mediated negative feedback loop (Fig 1A) adjusts overall mean
erythropoietic rate in the face of such fluctuations over time, but
the intrinsic delay in this loop may result in oscillations and limit
the system’s stability. Here we found that in the absence of Fas or
FasL, there was a significant increase in variability, reflected by
both increased variance and increased coefficient of variation, of
splenic ProE, EryA and EryB in individual mice, compared with
control mice (Fig 4B, Fig 5A). Bone-marrow erythroid subsets were
not affected, but there was increased variability of overall
erythropoietic rate, as reflected by the reticulocyte counts.
Therefore, Fas-mediated autoregulation in spleen has a stabilizing
effect on erythropoiesis at the whole animal level, offsetting the
limitations of the pO2/Epo-mediated negative feedback loop.
The stabilizing influence of the Fas/FasL interaction is a result
of its sensitivity to the size of the erythroblast pool. For
comparison, a recently identified cell-autonomous negative
regulator of splenic erythropoiesis in vivo, ERK1, does not appear
to contribute to the stability of erythropoiesis [49]. Fas -mediated
apoptosis of ProE or EryA depends on the probability that two
cells expressing Fas and FasL respectively, encounter each other
within the erythropoietic niche. This probability is dependent on
their frequency in tissue (Fig 2 and Text S2). Should their
frequency be in excess, Fas-mediated loss of EryA would
accelerate, providing an automatic correction. Conversely, a
shortage of EryA would lower the probability of their interaction
and death, allowing their number to increase. Both negative and
positive corrections take place locally in erythropoietic tissue, with
little delay and without the need to engage the pO2/Epo-mediated
negative feedback loop, avoiding potentially deleterious corrective
swings in systemic tissue pO2.
Fas-mediated Negative autoregulation accelerates the
stress response
Unexpectedly for mice lacking a negative erythropoietic
regulator, the response of gld-Rag12/2 and lpr-Rag12/2 mice to
acute Epo administration was delayed. The splenic EryA pool
expanded 30 fold its basal size in control mice by day 2; this
massive increase was reduced by 30% in the gld-Rag12/2 and lpr-
Rag12/2 mice, reflecting a significant shortfall, equivalent to 10
times the size of the basal EryA pool. This shortfall occurred in
spite of a larger than normal basal EryA pool in the mutant mice.
We found a similar delay in the expansion of ProE cells in the gld-
Rag12/2 and lpr-Rag12/2 mice.
To explain this phenomenon, we propose the model illustrated
in Figure 9. EryA are continuously formed from earlier
progenitors ( = EryA input) but the majority dies, with only a
small fraction remaining as the basal EryA pool. However, the
apoptosis-prone EryA form a reserve population that may be
rapidly recruited by high Epo during stress. We propose that the
rapid, 30-fold expansion in EryA within 2 days of Epo
administration corresponds to the size of the reserve EryA
population. The smaller initial expansion in the gld-Rag12/2
and lpr-Rag12/2 mice suggests that part of the EryA reserve is
regulated through Fas, and is missing in these mutant mice.
These observations suggest that the high apoptotic rates of ProE
and EryA in the basal state, in part due to Fas, provide a
mechanism that accelerates the stress response. The rescue of
ProE/EryA from apoptosis allows a faster increase in their number
compared with their generation by cell division from earlier
progenitors. This faster increase accelerates erythropoietic rate
and prevents a prolonged tissue hypoxia. We found that the
response of the erythropoietic system to reduced atmospheric
oxygen was similarly delayed in gld-Rag12/2 mice, as reflected by
lower reticulocyte counts and a slower increase in hematocrit. In
this more complex, hypoxic stimulus to the system, we noted that
the principal difference in the erythroblast pools between gld-
Rag12/2 and control mice appeared at the EryC stage, rather
than in the earlier, ProE and EryA stages. We suggest that this
may be due to accelerated maturation of erythroblasts, noted in
the older literature in response to hypoxic stress [46,47,48].
Of note, in ERK12/2 mice, the stress response is timely and
somewhat amplified [49]. Unlike Fas-mediated autoregulation,
which is exerted at the level of erythroblasts, ERK1 appears to
suppress a much earlier, BMP-dependent BFU-e progenitor,
which is therefore unlikely to contribute to the initial, acute phase
of stress.
Figure 9. Absence of a Fas-regulated EryA reserve delays the
response to stress. EryA cells are continuously formed from earlier
precursors (‘input’). In the basal state, when Epo concentrations are low,
only a small fraction of these cells survive, forming the ‘basal EryA pool’
(in purple). The remaining EryA undergo apoptosis, either through Fas
(‘Fas-regulated reserve’, green) or alternative mechanisms (‘Alternative
reserve’, blue). Together, the EryA reserve pools are 30 to 60 fold the
size of the basal pool (see Figure 6). During the initial response to stress,
high Epo levels rescue the EryA reserve pools from apoptosis, resulting
in an immediate increase in the size of the surviving EryA pool and an
increase in erythropoietic rate (solid colors indicate surviving cells,
dashed lines indicate cells that underwent apoptosis). We suggest that
lpr and gld mice partially compensate for the absence of the Fas-
regulated reserve by generating fewer EryA cells (a smaller input). In
this way, the absence of Fas –mediated apoptosis does not excessively
increase the basal EryA pool (which does increase 1.5–4 fold, see
Figure 5; this increase is much smaller than the stress-induced increased
and is not shown). During stress, the absence of the Fas-regulated
reserve in lpr and gld mice reduces the number of EryA that may be
immediately recruited into the surviving EryA pool and consequently
delays the stress response.
doi:10.1371/journal.pone.0021192.g009
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The negative autoregulatory motif
Negative autoregulation is a frequent motif in biological
networks. Computational and experimental approaches in simple
transcriptional networks in E.Coli suggested that it has two
principal effects: conferring resistance to random fluctuations, and
accelerating the response to a stimulus [32,33,34,35,56,57]. To
our knowledge, the functional role of negative autoregulation
within higher-level intercellular networks had not been tested
experimentally. Our work suggests that the negative regulatory
motif may exert similar ‘logic’ in higher-level networks, helping to
maintain both stability and a fast stress response of tissue
progenitors.
Supporting Information
Figure S1 Associated with Fig 1: Inhibition of Fas with Fas:Fc
decreases EryA death and increases erythropoietic rate. MyD882/2
mice (C57BL/6 background) were each injected intraperitoneally
with 100 mg human purified Fas:Fc chimeric protein (BD
Biosciences), or with an equal volume of saline. (A) Flow-cytometric
histogram of Annexin V binding of spleen EryA cells, showing
decreased apoptosis 48 hours following injection of Fas:Fc. (B)
Summary of Annexin V binding in two independent experiments, at
48 hours and at 72 hours post-injection. Data points correspond to
individual mice. (C) Summary of reticulocyte count (red blood cells
younger than 24 hr, identifiable by their cytoplasmic RNA, which is
absent in older red cells) in the same mice/experiments as in panel
(B). Fas:Fc caused an increase in reticulocytes, reflecting increased
erythropoietic rate.
(TIF)
Figure S2 Associated with Fig 5: Increased variance in lpr/gld
erythroid progenitor subsets. (A) Frequency distribution histo-
grams for EryA, in male and female gld-Rag12/2 and matched
Rag12/2 controls. The coefficient of variation for each group is
shown. Purple line is the corresponding normal distribution curve.
Same data set as in Fig 3D. A similar analysis for the lpr-Rag12/2
mice is shown in Figure 3E. (B) Coefficient of variation (CV) for
subsets ProE, EryA–C and retics in male or female lpr-Rag12/2 or
and gld-Rag12/2 mice and corresponding Rag12/2 controls. The
difference in CV between control and lpr/gld is significant at
p = 0.017 (paired t test, treating the CV as a standard statistical
variable).
(TIF)
Figure S3 Associated with Fig 6: Delayed response to Epo
injection in lpr-Rag12/2 mice. Female mice were injected with
10 U of Epo subcutaneously. Hematocrit, ProE and EryA
progenitors were measured on day 3 post injection. *p,0.05
(two-tailed t test, unequal variance). Basal hematocrit values are
for lpr-Rag12/2 females.
(TIF)
Table S1 Associated with Fig 3: Complete blood counts (CBC)
for the indicated mouse strains. Number of mice used for each strain
in each experiment is indicated in parentheses. HCT =hematocrit.
HGB =hemoglobin. RBC = red blood cells. MCV =mean
corpuscular volume. WBC =white blood cells. PLT =platelets.
All data are mean 6sem. t test (unequal variance) p values are
indicated.
(TIF)
Text S1 Supplementary Materials and Methods.
(DOCX)
Text S2 Regulation of the EryA progenitor pool by Fas.
(DOCX)
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